Showing 4981-4990 of 5771 results for "".
- Oxurion NV to Provide Business and Clinical Update at AAO and OIS Meetings in San Franciscohttps://modernod.com/news/oxurion-nv-to-provide-business-and-clinical-update-at-aao-and-ois-meetings-in-san-francisco/2476969/Oxurion NV announces that the company will be providing a business and clinical update at the American Academy of Ophthalmology’s annual meeting (AAO) and Ophthalmology Innovation Summit (OIS@AAO) in San Francisco. Patrik De Haes, MD, CEO of Oxurion will be presenting the company’s b
- EyeGate Pharma Completes Randomization in Pivotal Studyhttps://modernod.com/news/eyegate-pharma-completes-randomization-in-pivotal-study/2476965/EyeGate Pharmaceuticals announced that it has completed randomization for its corneal wound repair pivotal study using the Ocular Bandage Gel eye drop.
- AAO and Verana Health Accelerate Clinical Trials for Patients with Rare, Sight-Threatening Retinal Diseases Through Verana Trial Connecthttps://modernod.com/news/aao-and-verana-health-accelerate-clinical-trials-for-patients-with-rare-sight-threatening-retinal-diseases-through-verana-trial-connect/2476962/The American Academy of Ophthalmology (AAO) and Verana Health announced that they are now facilitating no-cost genetic testing and counseling for patients with certain inherited retinal diseases through Verana Trial Connect, a powerful cloud-based application that facilitates physician and patien
- Injectsense Demonstrates Animal-to-Cloud IOP Sensing Pathway for Glaucomahttps://modernod.com/news/injectsense-demonstrates-animal-to-cloud-iop-sensing-pathway-for-glaucoma/2476964/Injectsense announced completion of a successful in-vivo animal study of the first implantable sensor and monitoring system designed to collect long-term IOP data. The Injectsense IOP-Connect system creates an organ-to-cloud data connection that enables the clinician to assess glaucoma therapy ef
- Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and New IOL Data at AAOhttps://modernod.com/news/alcon-to-highlight-acrysof-iq-panoptix-trifocal-iol-launch-and-groundbreaking-iol-data-at-aao/2476961/Alcon announced its plans to lead a wide range of informational and peer-to-peer educational programs at the American Academy of Ophthalmology (AAO) annual meeting on October 12-15 in San Francisco. The newly launched AcrySof IQ PanOptix Trifocal IOL, along with findings from the AAO IRIS (Intell
- Genentech/Roche Complete Enrollment in YOSEMITE and RHINE Phase 3 Studies of Faricimab in DMEhttps://modernod.com/news/genentech-roche-complete-enrollment-in-yosemite-and-rhine-phase-3-studies-of-faricimab-in-dme/2476957/Genentech and Roche announced they have completed patient enrollment in the phase 3 YOSEMITE (
- Allegro to Present Clinical Research on the Novel Integrin-Regulating Portfolio at AAOhttps://modernod.com/news/allegro-to-present-clinical-research-on-the-novel-integrin-regulating-portfolio-at-aao/2476956/Allegro Ophthalmics announced that the results of its phase 2 clinical study of risuteganib (Luminate) for the treatment of intermediate nonexudative age-related macular degeneration (AMD) will be presented during AAO
- LensGen to Review Latest Juvene IOL Results At AAOhttps://modernod.com/news/lensgen-to-review-latest-juvene-iol-results-at-aao/2476954/LensGen will review its latest data for the world’s first modular fluid optic IOL in several activities around the American Academy of Ophthalmology (AAO) annual meeting in San Francisco this week. LensGen developed Juvene, which uses biomimetic design princ
- ImprimisRx to Focus on Investments in Quality at the 2019 AAO Meetinghttps://modernod.com/news/imprimisrx-to-focus-on-investments-in-quality-at-the-2019-aao-meeting/2476951/ImprimisRx announced its participation at the upcoming 2019 American Academy of Ophthalmology (AAO) annual meeting to be held in San Francisco, October 12-15. As part of ImprimisRx’s commitment to quality manufacturing, the company will be discussing its ongoing investments in cGMP (Curre
- Zeiss and Senorics Establish Partnership Focus on Joint Development of Sensor Technologyhttps://modernod.com/news/zeiss-and-senorics-establish-partnership-focus-on-joint-development-of-sensor-technology/2476952/Zeiss announced that it has invested in Dresden, Germany-based Senorics. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. on production lines for foodstuffs, agricultural products, pla